作者单位：
Department of Pathology and Experimental Therapeutics, University of Barcelona, Barcelona, Spain.
[1]
Senior Consultant, Bellvitge University Hospital, IDIBELL (Bellvitge Biomedical Research Centre), Barcelona, Spain.
[2]
CIBERNED (Network Centre of Biomedical Research of Neurodegenerative Diseases), Institute of Health Carlos III, Ministry of Economy and Competitiveness, Madrid, Spain.
[3]
Institute of Neurosciences, University of Barcelona, Barcelona, Spain.
[4]
Biology Unit, Scientific and Technical Services, Hospitalet de Llobregat, University of Barcelona, Barcelona, Spain.
[5]
Molecular and Cellular Neurobiotechnology, Institute of Bioengineering of Catalonia (IBEC), Barcelona Institute for Science and Technology, Parc Científic de Barcelona, Barcelona, Spain.
[6]
Department of Cell Biology, Physiology and Immunology, Faculty of Biology, University of Barcelona, Barcelona, Spain.
[7]
DOI
10.3389/fnagi.2019.00112
PMID
31191295
发布时间
2020-09-30
换一批
换一批
